ARCHIVES

NCI CTEP-Approved Trials For the Month of February

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

OMB Reprogramming Ban Criticized

September 20, 1985

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983